Role of Dapagliflozin in the Treatment of Heart Failure Reduced Ejection Fraction
Our Educational Symposium is designed for Administrators, Director of Nursing, and nursing staff that provide care to elderly and developmentally disabled persons. Our desire is to provide networking among leaders in the Post-Acute Care, Long Term Care, and Assisted Living industry while providing education on hot button issues. We hope that participants leave with the knowledge and tools to prepare them for the future.
This session will provide education on tools to improve the quality of care. The following topic will be presented: management of heart failure reduced ejection fraction with dapagliflozin.
Learning objectives include
- Review of current prescribing information for dapagliflozin.
- Review of dapagliflozin clinical data in heart failure reduced ejection fraction patients.
* Registration and attendance is complementary.
* This program is NOT associated with continuing education.
Executive Medical Science Liaison, Cardiovascular/Metabolic US Medical Affairs, AstraZeneca
Jenny is an Executive Medical Science Liaison in US Medical Affairs with AstraZeneca. She has worked for over two decades with AstraZeneca with a focus in cardiovascular medicine. Her primary responsibilities include scientific and clinical expertise with respect to brand medical strategy as well as to develop enhanced peer relationships with physicians and institutions in the cardiovascular arena. Her involvement extends to areas such as investigator sponsored research, support of clinical trials, disease state implementation initiatives, speaker programs and major conferences. During her time with AZ, she has worked on medications for the treatment of Heart Failure, Acute Coronary Syndrome, Dyslipidemia, and Hypertension. Her passion is the optimization of disease prevention and guideline directed medical therapy education in the treatment of cardiovascular disease. She has also is dedicated to women in heart disease programs and the advancement of women in medicine. Prior to joining AstraZeneca, her career included coagulation testing in clinical trials such as the GUSTO trials.
Jenny is a resident of the Greater Cincinnati, Ohio Area where she resides with her husband George and her Labrador, Cooper. She has two sons: George Phillips, Engineer in the Medical Industry, and Matthew, Logistics/Human Resource Student at Ball State University. Her spare time is spent with her family and outdoor activities.
Jenny is a graduate of Miami University (Bachelor of Science) and the University of Kentucky (Master of Science).